You are here

Long-Term Non-Interventional Latanoprost Study

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Universitair Ziekenhuis Antwerpen, Dienst Oftalmologie
Edegem, , 2650 Belgium
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Glaucoma, Ocular Hypertension
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0-17
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female

- Diagnosis of pediatric glaucoma or elevated intraocular pressure.

- Evidence of a personally signed and dated informed consent document indicating that
the subject (and/or a legally acceptable representative) has been informed of all
pertinent aspects of the study. A signed and dated assent will be required where
applicable according to local laws.

For treated subjects only:

- Continuously treated with latanoprost for at least 1 month within the year prior to
the baseline examination.

For untreated subjects only:

- Continuously treated with latanoprost or other topical prostaglandin analogues for
less than one month prior to the baseline examination (based on the best knowledge of
treating ophthalmologists), and unlikely to be treated with latanoprost or other
topical prostaglandin analogues during the three-year study period; OR

- No prior treatment with latanoprost or other topical prostaglandin analogues, and
unlikely to be treated with latanoprost or other topical prostaglandin analogues
during the three-year study period.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Unable/unwilling to comply with protocol.

- Pregnant or nursing females at baseline.

- For treated subjects only: a history of allergy or hypersensitivity to any of the
ingredients contained in latanoprost (e.g., hypersensitivity to benzalkonium
chloride).

NCT01265719
Pfizer
Completed
Long-Term Non-Interventional Latanoprost Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now